Mitchell Jones

Company: Palisade Bio

Job title: Chief Medical Officer

Seminars:

Detailing Characteristic of Fibrostenotic Crohn’s Disease Biology & the Potential of Locally Activated Pro-Drug PDE4 Inhibitor to Minimize OffTarget Effects & Maximize Therapeutic Efficacy 2:30 pm

Discussing the prevalence and clinical presentation of fibrostenotic Crohn’s disease, and the underlying biological mechanisms, focusing on fibrosis pathways and the role of chronic inflammation in disease progression Describing the mechanism of the PDE4 inhibitor and its dual antifibrotic and anti-inflammatory properties The innovative pro-drug approach allowing for local activation in the colon or distal…Read more

day: Day Two